William Blair Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-2,937
Closed -$232K 442
2016
Q3
$232K Sell
2,937
-866,484
-100% -$70.4M ﹤0.01% 441
2016
Q2
$72.5M Sell
869,421
-490,921
-36% -$43.6M 0.29% 114
2016
Q1
$125M Sell
1,360,342
-97,697
-7% -$8.81M 0.5% 76
2015
Q4
$148M Sell
1,458,039
-39,016
-3% -$4.06M 0.6% 55
2015
Q3
$147M Buy
+1,497,055
New +$166M 0.3% 101

Other funds holding GILD

William Blair Investment Management's GILD Position: Q4 2016 in Review

William Blair Investment Management sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 2,937 shares — an estimated $232K sold.

William Blair Investment Management first reported a position in GILD in Q3 2015 and held it in 5 quarters. The position peaked at $148M in Q4 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • William Blair Investment Management reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • William Blair Investment Management sold 2,937 Gilead Sciences shares in Q4 2016, an estimated $232K.
  • William Blair Investment Management first reported a position in Gilead Sciences in Q3 2015 and held it in 5 quarters.
  • William Blair Investment Management's Gilead Sciences position peaked at $148M in Q4 2015.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on William Blair Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.